Employee of the Month: Henry Huang
The Sanaria employee of the month for May 2021 is Henry Huang. Henry is Sanaria’s IT Manager and is also a member of the Vaccine Stabilization and Logistics team and was nominated for employee of the month for the IT system upgrade.
Employee of the Month: Ray Xu
The Sanaria employee of the month for April 2021 is Ray Xu. Ray is a member of the Facilities team and was nominated for employee of the month for taking the huge responsibility of our facilities engineering needs.
Employee of the Month: Ehud Inbar
The Sanaria employee of the month for March 2021 is Ehud Inbar. Ehud is a member of the Mosquito Production team and was nominated for employee of the month for his work with our Immune Deficient Mosquitoes grant as well as work on Protein Potentials Ty21a-COVID-19 vaccine development
Employees of the Month: Urvashi Rai and Alyssa Arnheim
The Sanaria employee of the month for February, 2021 are Urvashi Rai and Alyssa Arnheim. Urvashi is a member of the Vaccine Extraction and Model Systems team and was nominated for employee of the month for her support of the Quality Control team. Alyssa is a member of the Vaccine Extraction and Immunology Model Systems team and was nominated for employee of the month for her support of company operations during the pandemic.
Employee of the Month: Diana Perez
The Sanaria employee of the month for December 2020 is Diana Perez. Diana is a member of the Vaccine Stabilization and Logistics team and was nominated for employee of the month for her volunteer work and leadership with the company annual holiday party.
Sanaria Hosts Virtual i-PfSPZ-C Meeting
231 malaria researchers, regulators and funders from 68 institutions located in 27 different countries met virtually to share plans, insights and data, all aiming to advance the development of whole sporozoite malaria vaccines.
EUMF Investment of €12.9M in Sanaria Highlighted in BioBuzz Article
On December 2nd, 2020, the European Union Malaria Fund’s (EUMF) investment of €12.9 million in Sanaria Inc. was highlighted in an BioBuzz article written by Alex Keown.
The investment will fund the development of two Malaria vaccines, one Malaria prophylactic, and a SARS-CoV-2 vaccine. Sanaria is the first and only U.S.-based company that has received funding from the EUMF!
The full article can be accessed by this link.|
Presentations by the Bioko Island Malaria Elimination Project at the annual meeting of the American Society of Tropical Medicine and Hygiene.
Sanaria is proud to showcase posters from BIMEP that were displayed during ASTMH 2020.
Employee of the Month: Tint T. Wai
The Sanaria employee of the month for October 2020 is Tint T. Wai. Tint is a member of the purification team and was nominated for employee of the month for her work on the Ty21a-ORACOV:Ty21a-COVID 19 Vaccine development.
EU Malaria Fund: Sanaria to receive financing to develop Malaria vaccine
Sanaria to receive €12.9M for the development of two Malaria vaccines, one Malaria prophylactic, and a SARS-CoV-2 vaccine from the EU Malaria Fund.
Employee of the Month: Tooba Murshedkar
The Sanaria employee of the month for September 2020 is Tooba Murshedkar. Tooba is a member of the regulatory team and was nominated for employee of the month for leadership, dedication, tenacity, attention to the minutest detail, and fearlessness with our regulatory submissions program.
Sanaria PfSPZ Vaccines Wins Highly Commended Prophylactic Vaccine at the 13th Annual Vaccine Industry Excellence Awards
Sanaria's PfSPZ vaccines were shortlisted at the VIE awards with: Pfizer, Takeda, Janssen, Merck, Inovio, Geneone/Inovio, and BiondVax.
Sanaria’s Chief Executive and Scientific Officer, Dr. Hoffman, recognized as one of Ten International Vaccine Influencers Who Exemplify Maryland’s Leading Role in Public Health in BioBuzz
Dr. Stephen Hoffman, Sanaria's Chief Executive and Scientific Officer was recognized by BioBuzz as one of ten international vaccine influencers who exemplify Maryland's leading role in public health.
Sanaria’s Patents for Humanity Award Recognized in Virtual Ceremony hosted by the USPTO
Sanaria is recognized by USPTO in virtual ceremony for their Patents for Humanity Award.
Sanaria and Protein Potential Welcome Guest Speaker Dr. Golightly Who Spoke About Antiracism: Moving Beyond Good Hearts and Intentions
On September 1st, Sanaria and Protein Potential welcomed Dr. Linnie Golightly who presented on Antiracism.
Employee of the Month: Ayyappan Rathakrishnan
The Sanaria employee of the month for August, 2020 is Ayyappan Rathakrishnan Ayyappan is a member of the Quality Control team and was nominated for employee of the month for the tremendous support, extra work and extreme dedication he has shown.
USPTO Awards Sanaria with the 2020 Patents for Humanity Award
USPTO awards Sanaria with the 2020 Patents for Humanity Award for Sanaria's malaria vaccine.
OraCOV Vaccine against COVID-19
In collaboration with the University of Tübingen, Sanaria Inc. and Protein Potential, LLC are developing a vaccine against COVID-19: OraCOV
